newsfilter
← Latest News
GlobeNewswire·

Prime Medicine Announces Proposed $125.0 Million Public Offering of Common Stock

  • Prime Medicine, Inc. commenced an underwritten public offering of $125.0 million in shares of its common stock.
  • The company intends to grant underwriters a 30-day option to purchase up to an additional $18.75 million of shares.
  • All shares in the offering are being sold by Prime Medicine.
  • Jefferies, TD Cowen & Goldman Sachs & Co. LLC are acting as joint book-running managers.
  • Oppenheimer & Co. & LifeSci Capital are acting as passive book-running managers.
  • The offering is conducted pursuant to a Form S-3ASR shelf registration statement filed with the SEC on November 7, 2025, & amended in March 2026.
  • Final terms of the offering will be disclosed in a final prospectus supplement to be filed with the SEC.
Company
Prime Medicine, Inc.
Keywords
Nasdaq:PRME, Prime Medicine, Inc.